Publications by authors named "David Saperstein"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

52,797

Total Likes

1,050

Extended Reach

1,002,881

Social Features

266
P
Pattern Recognition Approach to Neuropathy and Neuronopathy.
Richard J Barohn, Gil I Wolfe, David S Saperstein, Mazen M Dimachkie

Neurol Clin· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory Evaluation of Peripheral Neuropathy.
David S Saperstein, Todd D Levine, Richard J Barohn, Jonathan S Katz, Mazen M Dimachkie

Neurol Clin· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Spectrum of Benign Lobular Inner Nuclear Layer Proliferations: A Multicenter Analysis and Review of the Literature.
Michael Javaheri, Christian J Sanfilippo, Sundeep K Kasi, Rachel Chen, Jose M Ruiz-Moreno, David A Saperstein

Ophthalmol Retina· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresolved issues with efgartigimod in CIDP, and broader concerns for future trial design.
Jonathan Katz, Liberty Jenkins, David Saperstein

J Neurol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal Tremor in Long COVID May Be a Symptom of Dysautonomia and Small Fiber Neuropathy.
Svetlana Blitshteyn, Ilene S Ruhoy, Lauren R Natbony, David S Saperstein

Neurol Int· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postural orthostatic tachycardia syndrome and other common autonomic disorders are not functional neurologic disorders.
Svetlana Blitshteyn, Glenn J Treisman, Ilene S Ruhoy, David S Saperstein, Jill R Schofield

Front Neurol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J Silvestri, David S Saperstein

Eur J Neurol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives.
Astra Dinculescu, Brian A Link, David A Saperstein

Int Ophthalmol Clin· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
Richard J Barohn, Byron Gajewski, Mamatha Pasnoor, Alexandra Brown, Laura L Herbelin, David Saperstein

JAMA Neurol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Fiber Neuropathy.
David S Saperstein

Neurol Clin· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3.
Todd D Levine, Jafar Kafaie, Lawrence A Zeidman, David S Saperstein, Reyanna Massaquoi

Muscle Nerve· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Jeffrey M Statland, Dan Moore, Yunxia Wang, Maureen Walsh, Tahseen Mozaffar, David Saperstein

Muscle Nerve· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study.
Todd D Levine, Jonathan S Katz, Richard Barohn, Leslie J Vaughan, Mazen M Dimachkie, David S Saperstein

Neurol Clin Pract· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal and hematologic side effects of long-term intravenous immunoglobulin therapy in patients with neurologic disorders.
Aidan A Levine, Todd D Levine, Kathie Clarke, David Saperstein

Muscle Nerve· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and Preventing Progressive Hearing Loss in Usher Syndrome III.
Ruishuang Geng, Akil Omar, Suhasini R Gopal, Daniel H-C Chen, Ruben Stepanyan, David Saperstein

Sci Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of safety of L-serine for ALS patients.
Todd D Levine, Robert G Miller, Walter G Bradley, Dan H Moore, David S Saperstein

Amyotroph Lateral Scler Frontotemporal Degener· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.
Zachary Macchi, Yunxia Wang, Dan Moore, Jonathan Katz, David Saperstein

Amyotroph Lateral Scler Frontotemporal Degener· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT).
Hendrik P N Scholl, Anthony T Moore, Robert K Koenekoop, Yuquan Wen, Gerald A Fishman, David A Saperstein

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
Mamatha Pasnoor, Jianghua He, Laura Herbelin, Ted M Burns, Sharon Nations, David Saperstein

Neurology· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.
Ted M Burns, Gordon A Smith, Jeffrey A Allen, Anthony A Amato, W David Arnold, David S Saperstein

Muscle Nerve· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Muscular Atrophy.
Teerin Liewluck, David S Saperstein

Neurol Clin· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients.
Todd D Levine, David S Saperstein

Clin Rheumatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.
Robert K Koenekoop, Ruifang Sui, Juliana Sallum, L Ingeborgh van den Born, Radwan Ajlan, David A Saperstein

Lancet· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired immune demyelinating neuropathies.
Mazen M Dimachkie, David S Saperstein

Continuum (Minneap Minn)· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis